Oxeia Biopharmaceuticals files Reg CF amendment correcting bonus-share perk date; DealMaker intermediary
- Form type
- Form C/A Reg CF amendment
- Amount
- Reg CF offering
- Filed
- 2026-11-20
- Platform
- DealMaker Securities
Non-material amendment correcting typographical errors, including a date in the Time-Based Bonus Shares perk, and replacing Exhibit I; DealMaker Securities is the intermediary.
Opens the filing on sec.gov
Share this filing
Permalink:
https://www.crowdfundinsider.com/filings/oxeia-biopharmaceuticals-dealmaker-reg-cf-amendment/